logo

For the Inventor, By the Inventor

Gainesville, FL, United States of America

Michael J Clare-Salzler

This inventor holds 8 USPTO granted patents and 1 published patent application. Top assignees: University of Florida Research Foundation Inc., University of California. Active years: 1995-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael J Clare-Salzler. Retrieved from https://idiyas.com/inventor/michael-j-clare-salzler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 87.5

Average Co-Inventor Count = 1.6

ph-index = 2

Forward Citations = 70(Granted Patents)


Location History:

  • Los Angeles, CA (US) (1995)
  • Gainesville, FL (US) (1997 - 2021)

Company Filing History:

goldMedal6 out of 3,052 
 
University of Florida Research Foundation Inc.
 patents
silverMedal2 out of 16,025 
 
University of California
 patents

Years Active: 1995-2021

Loading Chart...
8 patents (USPTO):Explore Patents
1. 10987314 - Antigen-specific, tolerance-inducing microparticles and uses thereof (2021-04-27),
2. 10016371 - Antigen-specific, tolerance-inducing microparticles and uses thereof (2018-07-10),
3. 6953578 - Materials and methods for detection and treatment of immune system dysfunctions (2005-10-11),
4. 6218133 - Materials and methods for detection and treatment of immune system dysfunctions (2001-04-17),
5. 6168792 - Materials and methods for detection and treatment of immune system dysfunctions (2001-01-02),
6. 5939069 - Materials and methods for detection and treatment of immune system (1999-08-17),
7. 5674978 - Peptides derived from glutamic acid decarboxylase (1997-10-07),
8. 5475086 - Cloned glutamic acid decarboxylase peptides (1995-12-12),

Title: Michael J Clare-Salzler: Innovator in Immunotherapy

Introduction

Michael J Clare-Salzler is a prominent inventor based in Gainesville, FL (US). He has made significant contributions to the field of immunotherapy, holding a total of 8 patents. His work focuses on developing innovative solutions for immune diseases and autoimmune disorders.

Latest Patents

One of his latest patents is titled "Antigen-specific, tolerance-inducing microparticles and uses thereof." This invention provides antigen-specific, tolerance-inducing microparticles designed for the targeted delivery of therapeutic agents to immune cells. The invention allows for the sustained release of therapeutic agents over a prolonged period, enhancing treatment efficacy. It also outlines therapeutic applications for the prevention and treatment of immune diseases and autoimmune disorders, with a specific embodiment aimed at treating type 1 diabetes.

Career Highlights

Michael has worked with notable organizations, including the University of Florida Research Foundation and the University of California. His career reflects a commitment to advancing medical science through innovative research and development.

Collaborations

Throughout his career, Michael has collaborated with esteemed colleagues such as Allan J Tobin and Mark G Erlander. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

Michael J Clare-Salzler's work in immunotherapy exemplifies the impact of innovation in addressing complex medical challenges. His contributions continue to pave the way for advancements in the treatment of autoimmune disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…